Spero Therapeutics, Inc. (SPRO)

1.205 +0.06 (+5.70%) USD  |  NASDAQ  |  Oct 09, 16:00
1.205 0.00 (0.00%) After-Hours: 16:11
More

Spero Therapeutics EPS Estimates for Current Quarter

EPS Estimates for Current Quarter Chart

View EPS Estimates for Current Quarter for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
May 19, 2025 --
April 02, 2025 --
March 31, 2025 --
February 21, 2025 --
January 30, 2025 --
December 31, 2024 --
December 02, 2024 --
Date Value
November 18, 2024 --
November 15, 2024 --
November 04, 2024 --
September 30, 2024 --
August 06, 2024 --
August 05, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Quarter Range, Past 5 Years

View EPS Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Current Quarter Benchmarks

View EPS Estimates for Current Quarter Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Kura Oncology, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade

EPS Estimates for Current Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade